SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
+38.23%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.11B
AUM Growth
+$243M
(+28%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
13.26%
Top 10 Holdings %
Top 10 Hldgs %
68.08%
Holding
74
New
16
Increased
14
Reduced
14
Closed
13
Top Buys
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$59.6M |
| 2 |
Y-mAbs Therapeutics
YMAB
|
$55.9M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$30.7M |
| 4 |
Sanofi
SNY
|
$18.4M |
| 5 |
ETTX
Entasis Therapeutics Holdings Inc.
ETTX
|
$12.8M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$14.6M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$10.5M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$8.96M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$8.8M |
| 5 |
BLUE
bluebird bio
BLUE
|
$8.69M |
Sector Composition
| 1 | Healthcare | 86.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Savara
SVRA
$643M
| $7.79M | 0.69% |
698,225
+441,533
| +172% | +$4.93M |
|
27
Exelixis
EXEL
$10.2B
| $7.15M | 0.64% |
+403,594
| New | +$7.15M |
|
28
AnaptysBio
ANAB
$613M
| $6.95M | 0.62% |
+69,615
| New | +$6.95M |
|
|
ADMS
29
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $6.92M | 0.62% |
345,756
+62,358
| +22% | +$1.25M |
|
|
AIMT
30
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $6.06M | 0.54% |
222,295
-152,749
| -41% | -$4.17M |
|
|
CHMA
31
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $5.87M | 0.52% |
1,767,102
| – | – |
|
32
Catalyst Pharmaceutical
CPRX
$2.48B
| $5.86M | 0.52% |
1,549,552
+99,595
| +7% | +$377K |
|
|
DERM
33
DELISTED
Dermira, Inc.
DERM
| $5.4M | 0.48% |
495,293
+130,953
| +36% | +$1.43M |
|
34
Amicus Therapeutics
FOLD
$2.46B
| $5.39M | 0.48% |
+445,969
| New | +$5.39M |
|
|
KDMN
35
DELISTED
Kadmon Holdings, Inc.
KDMN
| $5.15M | 0.46% |
1,842,502
+72,919
| +4% | +$204K |
|
|
BHVN
36
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5M | 0.45% |
+133,066
| New | +$5M |
|
37
Sarepta Therapeutics
SRPT
$1.96B
| $4.83M | 0.43% |
29,915
-18,485
| -38% | -$2.99M |
|
38
Rhythm Pharmaceuticals
RYTM
$6.78B
| $4.65M | 0.41% |
159,302
+19,002
| +14% | +$554K |
|
39
Kura Oncology
KURA
$713M
| $4.33M | 0.39% |
247,385
+79,485
| +47% | +$1.39M |
|
|
BPMC
40
DELISTED
Blueprint Medicines
BPMC
| $4.01M | 0.36% |
51,339
-40,861
| -44% | -$3.19M |
|
|
FOMX
41
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.83M | 0.34% |
668,619
-13,780
| -2% | -$79K |
|
42
Clearside Biomedical
CLSD
$27.2M
| $3.73M | 0.33% |
606,914
+174,010
| +40% | +$1.07M |
|
|
HSTO
43
DELISTED
Histogen Inc. Common Stock
HSTO
| $3.13M | 0.28% |
2,695
-1,599
| -37% | -$1.85M |
|
|
EPZM
44
DELISTED
Epizyme, Inc
EPZM
| $3.09M | 0.28% |
+291,318
| New | +$3.09M |
|
|
OTIC
45
DELISTED
Otonomy, Inc.
OTIC
| $2.72M | 0.24% |
987,778
+7,800
| +0.8% | +$21.4K |
|
46
PDS Biotechnology
PDSB
$56M
| $2.34M | 0.21% |
142,636
| – | – |
|
|
FSTX
47
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.29M | 0.2% |
+47,412
| New | +$2.29M |
|
|
ARQL
48
DELISTED
Arqule Inc
ARQL
| $2.19M | 0.2% |
+386,271
| New | +$2.19M |
|
49
Fate Therapeutics
FATE
$116M
| $1.71M | 0.15% |
+104,891
| New | +$1.71M |
|
50
Esperion Therapeutics
ESPR
$540M
| $1.62M | 0.14% |
36,599
-114,562
| -76% | -$5.08M |
|